Target Company Overview

ONE CREATION has invested in Aeris, a Swiss startup founded in 2015 by Pierre Bi and Constantin Overlack, which has developed an advanced suite of air purification products. Aeris utilizes cutting-edge technology and a unique filtering material to effectively combat the spread of bacteria, including COVID-19, and other pollutants in diverse indoor environments.

Aeris focuses on enhancing indoor air quality with applications spanning from residential use to healthcare and building ventilation. The company's strength lies in its superior filtering capabilities without causing a drop in pressure within ventilation systems, which in turn allows for reduced energy consumption while achieving more effective filtration.

Industry Overview in Switzerland

The air purification industry is experiencing significant growth globally, particularly in Switzerland, where environmental consciousness and public health awareness have risen sharply. The increasing number of airborne diseases and urban pollution concerns are driving demand for advanced air filtration solutions. The Swiss government is actively promoting initiatives aimed at improving air quality, which is benefitting companies like Aeris.

The sector is also influenced by stringent regulatory standards that mandate improved air quality in indoor spaces, creating a favorable environment for innovation and investment in air purification technologies. Moreover, as more consumers recognize the importance of clean air, the market for air purification products is expanding across residential, commercial, and industrial domains.

In recent years, the industry has seen a surge in technological advancements, allowing for the development of more effective and efficient purification systems. This has resulted in an array of product offerings, catering to various needs and preferences among consumers and businesses alike.

Rationale Behind the Deal

ONE CREATION firmly believes that investing in Aeris aligns with their vision of fostering innovative technologies that enhance environmental conditions for individuals while optimizing energy efficiency. With the growing body of evidence linking air quality to health outcomes, investing in a company poised for substantial growth in a booming industry represents a strategic opportunity.

The exceptional sales growth of Aeris, which reached US$ 7.8 million in 2020 with over 700% growth, showcases the company's robust market demand and indicates strong potential for future expansion.

Investor Information

ONE CREATION is a forward-thinking investment firm dedicated to supporting enterprises that prioritize sustainability and technological innovation. Their mission centers on investing in companies that strive to make a positive environmental impact while offering bold solutions for a better tomorrow.

With a deep understanding of market trends and an impressive portfolio, ONE CREATION is committed to leveraging its resources to foster the growth of companies like Aeris, which align with its core values and long-term vision.

View of Dealert

This deal is poised to be a worthwhile investment as the air purification market continues to expand, fueled by a combination of health consciousness and regulatory changes. Aeris's unique selling propositions, including their energy-efficient filtration technology, position the company advantageously within this competitive landscape.

Additionally, the increasing awareness around the importance of indoor air quality post-pandemic enhances Aeris's value proposition and market appeal. With a diverse target market encompassing residential, healthcare, and commercial sectors, their growth trajectory appears promising.

Furthermore, ONE CREATION's commitment to sustainability aligns perfectly with Aeris's mission, reinforcing the potential for a successful partnership that will drive innovation while addressing urgent environmental challenges. Overall, this investment represents a strategic alignment that is likely to yield significant returns for all stakeholders involved.

View Original Article

Similar Deals

Momenta AICA

2025

Seed Stage Other Switzerland
Buenavista Medyria AG

2025

Seed Stage Other Switzerland
Investiere, ZKB, HTGF Qnami

2023

Seed Stage Other Switzerland
allygatr Board Owl

2023

Seed Stage Other Switzerland
Nivalis Group ROVENSO

2019

Seed Stage Other Switzerland
Rieter Barmag

2025

Buyout Other Switzerland
M Ventures NovoLINC

2025

Seed Stage Other United States of America
Seafund Calligo Technologies

2025

Seed Stage Other India
VH Bwell Supplements

2025

Seed Stage Other Other
MIG Fonds ASTRA Therapeutics

2025

Seed Stage Biotechnology & Medical Research Switzerland

ONE CREATION

invested in

Aeris

in 2023

in a Seed Stage deal

Disclosed details

Revenue: $8M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert